CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.

CRL | NYSE

Overview

Corporate Details

ISIN(s):: US1598641074
LEI:
Country:: United States of America
Address:: 251 BALLARDVALE ST, 1887 WILMINGTON
Website:: https://www.criver.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Charles River Laboratories International, Inc., founded in 1947, is a leading global contract research organization (CRO). The company provides essential products and services to support the entire drug discovery and development continuum for the pharmaceutical, biotechnology, and medical device industries. Its offerings span from early-stage research and discovery to non-clinical development, safety assessment, and manufacturing solutions. A key component of its business is the provision of a wide range of research models for laboratory testing. By partnering with clients worldwide, Charles River aims to accelerate the development of novel therapies, ensuring they are brought to market safely and efficiently.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CHAMPIONS ONCOLOGY, INC. Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.	United States of America	CSBR
Ch. Charilaou Group Plc A tour operator selling travel packages and developing online reservation platform solutions.	Cyprus	CHCH
Cheil Worldwide Inc Creates data-driven, integrated marketing and connected experiences for global brands.	South Korea	030000
Chiome Bioscience Inc. Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.	Japan	4583
Chordia Therapeutics,Inc Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.	Japan	190A
CHOSA Oncology AB Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.	Sweden	CHOSA
Cidara Therapeutics, Inc. Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.	United States of America	CDTX
CINC Corp. Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.	Japan	4378
CIRCULATION Co.,Ltd. Connects corporations with experts for project-based consulting to solve business challenges.	Japan	7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Developing a CIZ1B biomarker blood test for the early detection of lung cancer.	United Kingdom	CIZ